Product

MLYAAT-1002

Aliases

Fractional picosecond laser treatment followed by daily use of formulations containing MLYAAT-1002®., Fractional picosecond laser treatment followed by daily use of formulations without MLYAAT-1002®

1 clinical trial

3 indications

Indication

Skin Manifestations

Indication

Wrinkle

Indication

Photoaging

Clinical trial

Clinical Study on 56-Day Continuous Improvement of 1064nm Fractional Picosecond Laser Treatment With Formulations of A Proprietary Anti-aging Complex Composition

Status: , Estimated PCD: 2024-01-28